Candesartan cilexetil (Candesartan Austell)
Candesartan cilexetil
Austell Pharmaceuticals (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Austell Pharmaceuticals (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Candesartan 8 MG austell EACH TABLET CONTAINS: CANDESARTAN CILEXETIL 8,0 mg | 8 mg | 49005149/7.1.3/0051 | Cancelled | Not determined | None |
| Candesartan 16 MG austell EACH TABLET CONTAINS: CANDESARTAN CILEXETIL 16,0 mg | 16 MG | 49005249/7.1.3/0052 | Cancelled | Not determined | None |
| Candesartan 32 MG austell EACH TABLET CONTAINS: CANDESARTAN CILEXETIL 32,0 mg | 32 MG | 49005349/7.1.3/0053 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
Drag to rotate. Structure from PubChem CID 2540.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.